[Dr.Kats]

“Six proposed COVID‐19 therapeutics were identified as possessing ototoxic side effects including chloroquine and hydroxychloroquine, azithromycin, lopinavir‐ritonavir, interferon, ribavirin, and ivermectin.”

“Many previously or currently used COVID‐19 therapeutics have known ototoxicity including antimalarials, macrolide antibiotics, immunomodulatory agents, and antiviral therapies. Ototoxicity refers to drugs that cause functional impairment or cellular damage to tissues of the inner ear including both the cochlear and vestibular system, often manifesting as hearing loss, tinnitus or disequilibrium.”

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014300/

ncbi.nlm.nih.gov

A Narrative Review of Pharmacologic Treatments for COVID‐19: Safety Considerations and Ototoxicity - PMC

The purpose of this review is to summarize evidence‐based data regarding the ototoxic effects of potential COVID‐19 therapeutics to treat patients suffering from SARS‐CoV‐2. Medications under investigation as novel therapeutics to treat COVID‐19 ...